Report Date

02/09/2026

Case Against

Betsi Cadwaladr University Health Board

Subject

Adult Mental Health

Case Reference Number

202505039

Outcome

Upheld in whole or in part

Miss C complained about the care and management she received from the Health Board. She complained about whether the long-term prescribing of zopiclone (used to treat her insomnia) was appropriate and whether the risks and benefits were adequately communicated to her.

The Ombudsman’s investigation found that prescribing zopiclone on a long-term basis was not appropriate in Miss C’s case and was contrary to medication prescribing guidelines. The Ombudsman upheld this aspect of her complaint.

The Ombudsman was unable, in the absence of documented evidence, to conclude that the risks and benefits of long-term use of zopiclone were adequately communicated to Miss C. The investigation found that poor documentation evidence in this case amounted to maladministration. It was to this extent only that Miss C’s complaint was upheld.

The recommendations made by the Ombudsman included the Health Board apologising to Miss C for the failings identified and providing a reminder to clinicians around patient documentation including the need to set out the rationale behind the prescribing, especially where medication can cause dependency and the dosage exceeds national medication prescribing guidance.